back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-01-05 16:53 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+25,500 vol |
49,500 | |
| Filed 2022-01-05 16:51 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+17,000 vol |
115,783 | |
| Filed 2021-06-12 10:07 Tx date 2021-06-10 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,720
+1,155 vol $1.49 each |
15,145 | |
| Filed 2021-06-12 10:06 Tx date 2021-06-10 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$870.00
+600 vol $1.45 each |
13,990 | |
| Filed 2021-06-12 10:06 Tx date 2021-06-10 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,620
+3,300 vol $1.40 each |
13,390 | |
| Filed 2021-06-12 10:05 Tx date 2021-06-10 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$973.00
+700 vol $1.39 each |
10,090 | |
| Filed 2021-03-12 16:14 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2021-03-12 16:13 Tx date 2016-09-12 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 16:12 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,625 vol |
98,783 | |
| Filed 2020-03-27 16:08 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+6,250 vol |
93,158 | |
| Filed 2019-04-16 10:01 Tx date 2019-04-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
86,908 | |
| Filed 2018-10-04 Tx date 2018-10-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+8,500 vol |
64,408 | |
| Filed 2018-05-17 Tx date 2018-05-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+5,390 vol |
9,390 | |
| Filed 2018-05-17 Tx date 2018-05-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-5,390 vol |
1,000 | |
| Filed 2018-03-29 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$19,996
+5,390 vol $3.71 each |
6,390 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+49,758 vol |
55,908 | |
| Filed 2016-09-12 Tx date 2016-09-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
6,150 | ||
| Filed 2016-09-12 Tx date 2016-09-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,000 | ||
| Filed 2016-09-12 Tx date 2016-09-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000 |